Eiger Biopharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Eiger Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eiger Biopharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eiger Biopharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.6k | 21k | 0.22 |
| 2023-09-30 | $6.3k | 21k | 0.31 |
| 2023-06-30 | $35k | 50k | 0.70 |
| 2023-03-31 | $146k | 162k | 0.90 |
| 2022-12-31 | $159k | 135k | 1.18 |
| 2022-09-30 | $1.0M | 138k | 7.43 |
| 2022-06-30 | $732k | 117k | 6.24 |
| 2022-03-31 | $1.0M | 121k | 8.32 |
| 2021-12-31 | $639k | 127k | 5.05 |
| 2021-09-30 | $816k | 125k | 6.54 |
| 2021-06-30 | $985k | 116k | 8.53 |
| 2021-03-31 | $919k | 104k | 8.85 |
| 2020-12-31 | $1.3M | 105k | 12.27 |
| 2020-09-30 | $768k | 94k | 8.14 |
| 2020-06-30 | $885k | 92k | 9.66 |
| 2020-03-31 | $522k | 77k | 6.80 |
| 2019-12-31 | $1.1M | 76k | 14.85 |
| 2019-09-30 | $762k | 74k | 10.28 |
| 2019-06-30 | $769k | 73k | 10.57 |
| 2019-03-31 | $328k | 24k | 13.96 |
| 2018-12-31 | $199k | 20k | 10.10 |
| 2018-09-30 | $237k | 20k | 11.88 |
| 2018-06-30 | $249k | 20k | 12.18 |
| 2018-03-31 | $148k | 15k | 9.92 |
| 2017-12-31 | $199k | 14k | 13.96 |
| 2017-06-30 | $117k | 15k | 8.02 |
| 2017-03-31 | $158k | 14k | 11.50 |
| 2016-12-31 | $151k | 13k | 11.56 |
| 2016-09-30 | $164k | 12k | 13.32 |
| 2016-06-30 | $214k | 11k | 19.85 |